CNMD — CONMED Corp

NYSE · Health Care · Health Care Equipment & Supplies · CIK 816956 ·
Last close
$51.49
Market Cap
$1.54B
52W High
$53.66
52W Low
$31.44
ADV30
545,898
Next earnings
2026-07-29
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026 343,488,000 197,458,000 36,405,000 23,071,000 2,300,306,000 37,328,000 1,258,916,000
Mar 2026 317,046,000 183,447,000 25,415,000 13,828,000 2,314,942,000 35,030,000 1,297,269,000
Dec 2025 373,198,000 218,285,000 36,624,000 16,739,000 2,325,749,000 40,817,000 1,292,652,000
Sep 2025 337,926,000 166,119,000 11,879,000 2,859,000 2,322,488,000 38,929,000 1,314,225,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$150,588,000
Investing CF
$3,376,000
Financing CF
$-149,682,000
CapEx
$-16,124,000
Dividends Paid
$-12,380,000
Buybacks
$-43,221,000
EPS Diluted TTM
$1.85
As of
2026-08-02

Balance + Analyst (yfinance extras)

Retained Earnings
$625,665,000
Inventory
$360,179,000
Receivables
$239,770,000
ST Investments
EBIT TTM
$113,148,000
Pretax Income TTM
$83,228,000
Interest Exp TTM
$29,920,000
Analysts
6

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,371,657,984
EBITDA
$227,460,992
Free Cash Flow
$131,359,624
Enterprise Value
$2,326,531,328
Total Cash
$37,328,000
Total Debt
$834,249,024
Shares Out
29,951,248
Trailing EPS
$1.85
Book Value
$34.73
ROE
5.5%
ROA
4.1%
Div Yield
1.57%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,374,724,000 102,622,000 47,055,000 2,325,749,000 1,292,652,000 170,689,000
Dec 2024 1,307,015,000 200,326,000 132,423,000 2,306,247,000 1,343,566,000 166,968,000
Dec 2023 1,244,744,000 120,603,000 64,459,000 2,300,021,000 1,465,799,000 125,348,000
Dec 2022 1,045,472,000 70,054,000 -80,582,000 2,297,592,000 1,552,047,000 33,365,000

TTM Snapshot

Revenues TTM
$1,145,194,000
NetIncome TTM
$125,919,000
OpCashFlow TTM
$0
Assets (Latest)
$2,306,247,000
Forward EPS
$4.78

Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)

max pain strike: $35.00 · spot: $51.49 · call volume: 22 · put volume: 13

Peers — same industry

TickerNameMarket CapLastDaily %
TNDM TANDEM DIABETES CARE INC $1.55B $22.22
KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. $1.58B $26.91
ENOV Enovis CORP $1.45B $25.21
ATEC Alphatec Holdings, Inc. $1.42B $9.24
CDRE Cadre Holdings, Inc. $1.42B $33.08

News headlines (Yahoo Finance, 1h cache)

The Bull Case For CONMED (CNMD) Could Change Following Shift In Regulatory Tailwinds Across Its Surgical Portfolio
2026-08-18 11:10 · Yahoo
CNMD Jumps 16% in a Month as Investors Assess Whether It Can Last
2026-08-17 19:12 · Yahoo
Can CONMED's Raised 2026 EPS Outlook Reinforce Its Growth Momentum?
2026-08-17 19:06 · Yahoo
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
2026-08-17 19:05 · Yahoo
Why Are CONMED (CNMD) Shares Soaring Today
2026-07-30 22:13 · Yahoo
CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands
2026-07-30 16:49 · Yahoo
CONMED’s (NYSE:CNMD) Q2 CY2026: Beats On Revenue, Stock Soars
2026-07-29 20:27 · Yahoo
CONMED Corporation Reports Second Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
2026-07-29 20:05 · Yahoo
Earnings To Watch: CONMED (CNMD) Reports Q2 Results Tomorrow
2026-07-28 07:25 · Yahoo
Is CONMED (CNMD) A Bargain Following Its SRS Meeting Spotlight?
2026-07-27 04:25 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.